Miranda, Marissa C.
HRN: 22-07-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/21/2024
03/28/2024
IVT
4.5g
Q6
CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes